| Perioperative systemic therapy and cytoreductive surgery with HIPEC versus upfront cytoreductive surgery with HIPEC alone for isolated resectable colorectal peritoneal … KP Rovers, C Bakkers, GAAM Simkens, JWA Burger, SW Nienhuijs, ... Bmc Cancer 19, 1-15, 2019 | 89 | 2019 |
| Overview of elements within national food-based dietary guidelines I van ‘t Erve, CBM Tulen, J Jansen, ADE van Laar, R Minnema, PR Schenk, D ... European Journal of Nutrition & Food Safety 6 (4), 172-227, 2017 | 40 | 2017 |
| Perioperative systemic therapy vs cytoreductive surgery and hyperthermic intraperitoneal chemotherapy alone for resectable colorectal peritoneal metastases: a phase 2 … KP Rovers, C Bakkers, SW Nienhuijs, JWA Burger, GJM Creemers, ... JAMA surgery 156 (8), 710-720, 2021 | 37 | 2021 |
| Detection of tumor‐derived cell‐free DNA from colorectal cancer peritoneal metastases in plasma and peritoneal fluid I Van't Erve, KP Rovers, A Constantinides, K Bolhuis, ECE Wassenaar, ... The Journal of Pathology: Clinical Research 7 (3), 203-208, 2021 | 28 | 2021 |
| Repetitive electrostatic pressurised intraperitoneal aerosol chemotherapy (ePIPAC) with oxaliplatin as a palliative monotherapy for isolated unresectable colorectal peritoneal … KP Rovers, RJ Lurvink, ECE Wassenaar, TJM Kootstra, HJ Scholten, ... BMJ open 9 (7), e030408, 2019 | 24 | 2019 |
| Diagnostic strategies toward clinical implementation of liquid biopsy RAS/BRAF circulating tumor DNA analyses in patients with metastatic colorectal cancer I van't Erve, MJE Greuter, K Bolhuis, DCL Vessies, A Leal, GR Vink, ... The Journal of Molecular Diagnostics 22 (12), 1430-1437, 2020 | 22 | 2020 |
| Postoperative circulating tumour DNA is associated with pathologic response and recurrence-free survival after resection of colorectal cancer liver metastases K Bolhuis, I van't Erve, C Mijnals, PM Delis–Van Diemen, J Huiskens, ... EBioMedicine 70, 2021 | 21 | 2021 |
| Metastatic colorectal cancer treatment response evaluation by ultra-deep sequencing of cell-free DNA and matched white blood cells I van't Erve, JE Medina, A Leal, E Papp, J Phallen, V Adleff, EJ Chiao, ... Clinical Cancer Research 29 (5), 899-909, 2023 | 17 | 2023 |
| KRAS A146 Mutations Are Associated With Distinct Clinical Behavior in Patients With Colorectal Liver Metastases I Van't Erve, NJ Wesdorp, JE Medina, L Ferreira, A Leal, J Huiskens, ... JCO precision oncology 5, 1758-1767, 2021 | 16 | 2021 |
| Changes in circulating levels of 25-hydroxyvitamin D3 in breast cancer patients receiving chemotherapy DE Kok, MMGA van den Berg, L Posthuma, I van’t Erve, ... Nutrition and cancer 71 (5), 756-766, 2019 | 11 | 2019 |
| First-line palliative systemic therapy alternated with electrostatic pressurised intraperitoneal aerosol chemotherapy (oxaliplatin) for isolated unresectable colorectal … RJ Lurvink, P Rauwerdink, KP Rovers, ECE Wassenaar, MJ Deenen, ... BMJ open 11 (3), e044811, 2021 | 10 | 2021 |
| Dutch Peritoneal Oncology Group (DPOG); Dutch Colorectal Cancer Group (DCCG). Perioperative systemic therapy and cytoreductive surgery with HIPEC versus upfront cytoreductive … KP Rovers, C Bakkers, G Simkens, JWA Burger, SW Nienhuijs, ... BMC Cancer 19 (1), 390, 2019 | 7 | 2019 |
| LBA-6 safety, feasibility, tolerability, and preliminary efficacy of perioperative systemic therapy for resectable colorectal peritoneal metastases: pilot phase of a randomised … K Rovers, C Bakkers, S Nienhuijs, J Burger, G Creemers, ... Annals of Oncology 31, S243, 2020 | 2 | 2020 |
| Identifying Genetic Mutation Status in Patients with Colorectal Cancer Liver Metastases Using Radiomics-Based Machine-Learning Models N Wesdorp, M Zeeuw, D van der Meulen, I van ‘t Erve, Z Bodalal, J Roor, ... Cancers 15 (23), 5648, 2023 | 1 | 2023 |
| Limited release of circulating tumor DNA into the systemic circulation by peritoneal metastases from colorectal cancer I van't Erve, KP Rovers, A Constantinides, K Bolhuis, EC Wassenaar, ... Cancer Research 80 (16_Supplement), 708-708, 2020 | 1 | 2020 |
| Identifying genetic mutation status in patients with colorectal liver metastases using radiomics based machine learning models NJ Wesdorp, JM Zeeuw, D van der Meulen, I van‘t Erve, Z Bodalal, J Roor, ... HPB 26, S21, 2024 | | 2024 |
| A scenario‐drafting study to explore potential future implementation pathways of circulating tumor DNA testing in oncology A Kramer, C Rubio‐Alarcón, D van den Broek, DCL Vessies, I Van't Erve, ... Molecular oncology, 2023 | | 2023 |
| Cell-free DNA fragmentation profiling for therapeutic response monitoring in metastatic colorectal cancer. ZL Skidmore, I van't Erve, K Lumbard, B Alipanahi, L Keefer, L Rinaldi, ... Journal of Clinical Oncology 41 (16_suppl), e15664-e15664, 2023 | | 2023 |
| Cell-free DNA fragmentation profiling for monitoring therapeutic response in metastatic colorectal cancer B Alipanahi, I van't Erve, K Lumbard, LK Millberg, Z Skidmore, L Rinaldi, ... Cancer Research 83 (7_Supplement), 5714-5714, 2023 | | 2023 |
| Ultra-deep targeted sequencing of cell-free DNA and patient-matched white blood cells for treatment response evaluation in patients with metastatic colorectal cancer I Erve, JE Medina, A Leal, E Papp, J Phallen, V Adleff, EJ Chiao, AS Arun, ... Cancer Research 83 (7_Supplement), 5587-5587, 2023 | | 2023 |
